Skip to content

Martin Kusz, DO

NPI 1407590557ActiveIndividual· Internal Medicine· Fountain Hill, PA

Internal Medicine (DO) in Fountain Hill, Pennsylvania, licensed in PA and NJ, with an NPI issued in April 2022. Part D covered 119 prescriptions written in 2024, 89% of them generic. Novo Nordisk Inc reported $18.35 in payments in 2025, mostly food and beverage.

Overview

NPI1407590557
StatusActive
Entity typeIndividual
CredentialDO
Sole proprietorNo
NPI issuedApr 25, 2022
Last updated in NPPESMar 20, 2026
Certified by providerMar 20, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000XOS025274PA
Internal Medicine207R00000X25MB12320100NJ

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)119 · 269 30-day fills
Patients40
Total drug cost$14,996
Generic share89% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$18.35 · 1 payment from 1 company
  • 2024$66.49 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$18.351

What the 2025 payments were for

  • Food and Beverage$18.35 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other internal medicine physicians in Fountain Hill

All internal medicine physicians in Pennsylvania